Discharging patients the same day that they undergo robotic urologic surgery during the COVID-19 pandemic did not increase their risk for complications or readmission, a study found.
A new study suggests that outcomes may be better with top-performing surgeons.
This tool can help urologists, oncologists and surgeons create better treatment plans so their patients can have more precise treatment.
Movement builds to classify Gleason 6 prostate lesions as nonmalignant
An article from The “New” Prostate Cancer Infolink
Watch this video addressing treatment advances in the non-metastatic castration-resistant prostate cancer space, focusing on the data and clinical implications of the ARAMIS trial.